metastatic-breast-cancer

Documents about metastatic-breast-cancer

• Sitravatinib in Metastatic Breast Cancer#914925ClinicalTrials.gov
• Epidemiology and Management of Metastatic Breast Cancer#1057709ClinicalTrials.gov
• Exemestane With Sunitinib (SUTENT®) in Metastatic Breast Cancer#887611ClinicalTrials.gov
• First Line Therapy for Patients With Metastatic Breast Cancer#1094747ClinicalTrials.gov
• Exercise in Metastatic Breast Cancer: EMBody#801868ClinicalTrials.gov
• Immunologic Targeting of ESR1 Receptor for Hormone Receptor Expressing Metastatic Breast Cancer#860890ClinicalTrials.gov
• TIL Gean Therapy Combined With Immunotherapy for Advanced or Metastatic Refractory Breast Cancer#268031ClinicalTrials.gov
• ACY-1215 + Nab-paclitaxel in Metastatic Breast Cancer#1032845ClinicalTrials.gov
• Combination Study of SV-BR-1-GM With Retifanlimab#234415ClinicalTrials.gov
• A Pilot Study Utilizing Proteomic and Genomic Profiling for Patients With Metastatic Breast Cancer#874152ClinicalTrials.gov
• A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast Cancer#1075529ClinicalTrials.gov
• Patient-reported Outcome Questionnaire for Women With Metastatic Breast Cancer#886852ClinicalTrials.gov
• SU11248 as Consolidation After Response to Taxanes in Metastatic Breast Cancer#915542ClinicalTrials.gov
• Local Surgery for Metastatic Breast Cancer#906976ClinicalTrials.gov
• Phase I/II Study of AZD2281 Given in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer#801676ClinicalTrials.gov
• A Study to Determine Safety and Tolerability of GMI-1359 in Subjects With HR+ Metastatic Breast Cancer#839876ClinicalTrials.gov
• Vinorelbine Versus Gemcitabine Plus Vinorelbine in Metastatic Breast Cancer Patients#888373ClinicalTrials.gov
• Trial of Myocet in Metastatic Breast Cancer#832036ClinicalTrials.gov
• Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Breast Cancer#969681ClinicalTrials.gov
• Abraxane in Treatment of Metastatic Breast Cancer#838680ClinicalTrials.gov
• Plant-Based Nutrition for Breast or Endometrial Cancer#1007069ClinicalTrials.gov
• T-DM1 With Abraxane and Lapatinib for Metastatic HER2 Positive Breast Cancer#880802ClinicalTrials.gov
• Mono Efficacy of Capecitabine (MoniCa)#840892ClinicalTrials.gov
• Everolimus trIal for Advanced prememopausaL Breast Cancer Patients#913956ClinicalTrials.gov
• Addition of Aromatase at the Navelbine in Pretreated Metastatic Breast Cancer.#968436ClinicalTrials.gov
• Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer#1030447ClinicalTrials.gov
• Gemcitabine Plus Bevacizumab in Locally Recurrent or Metastatic Breast Cancer#1073421ClinicalTrials.gov
• A Trial to Evaluate the Combination of Iressa & Faslodex® in Patients With Advanced or Metastatic Breast Cancer#902300ClinicalTrials.gov
• Predicting Olaparib Sensitivity in Patients With Unresectable Locally Advanced/Metastatic HER2-negative Breast Cancer.#836341ClinicalTrials.gov
• Evaluation of Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated With Metronomic Cyclophosphamide#902685ClinicalTrials.gov
• A Randomized Study of TH Versus THL in First Line Treatment of HER2-positive Metastatic Breast Cancer#911601ClinicalTrials.gov
• Ribociclib + PDR001 in Breast Cancer and Ovarian Cancer#307438ClinicalTrials.gov
• Capecitabine With Digoxin for Metastatic Breast Cancer#805495ClinicalTrials.gov
• Metastatic Breast Cancer Treatment Planning#860273ClinicalTrials.gov
• Olaparib Maintenance Therapy in Metastatic Breast Cancer#868683ClinicalTrials.gov
• Liposomal Doxorubicin and Docetaxel in Metastatic Breast Cancer#899794ClinicalTrials.gov
• Combination Weekly Taxotere™ With Iressa™ /Placebo in Metastatic Breast Cancer#913206ClinicalTrials.gov
• Oral Zn-Telomir Monotherapy in Patients With Advanced or Metastatic Triple-Negative Breast Cancer (TNBC)#844744ClinicalTrials.gov
• A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer#979028ClinicalTrials.gov
• The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer#1047343ClinicalTrials.gov
• PVX-410 Vaccine Plus Pembrolizumab in HLA-A2+ Metastatic Triple Negative Breast Cancer#405149ClinicalTrials.gov
• Vinorelbine/Gemcitabine Versus Vinorelbine/Cisplatin in Metastatic Breast Cancer#860835ClinicalTrials.gov
• Phase Ⅱ Clinical Study of R435 (Bevacizumab) in Combination With Paclitaxel in Patients With Inoperable Metastatic Breast Cancer#1093574ClinicalTrials.gov
• Study of BKM120 or BYL719 and Capecitabine in Patients With Metastatic Breast Cancer#1032029ClinicalTrials.gov
• Fulvestrant, Palbociclib and Erdafitinib in ER+/HER2-/FGFR-amplified Metastatic Breast Cancer#890751ClinicalTrials.gov
• Safety and Tolerability of MSI-1436C in Metastatic Breast Cancer#868663ClinicalTrials.gov
• Exemestane + Celecoxib vs Exemestane + Placebo in Metastatic Breast Cancer#911384ClinicalTrials.gov
• Adenovirus Encoding Rat HER-2 in Patients With Metastatic Breast Cancer (AdHER2.1)#283084ClinicalTrials.gov
• SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer#256886ClinicalTrials.gov
• Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)#903658ClinicalTrials.gov